DNA methylation-regulated SNX20 overexpression correlates with poor prognosis, immune cell infiltration, and low-grade glioma progression
Figure 1.SNX20 is highly expressed in LGG. (A) The expression of SNX20 in pan-cancer examined by TCGA database. (B–D) The expression of SNX20 in LGG examine by TCGA/GEO databases.